Sibutsetelo se-Paroxysmal Nocturnal Hemoglobinuria

Ukuphazamiseka Kubangelwa Umthetheli Ezingxenyeni Zegazi

I-Paroxysmal nocturnal hemoglobinuria (i-PNH) i-blood stem cell disorder etholakalayo. Kwakubizwa ngokuthi okokuqala uphawu lwaso lomchamo omnyama (i-hemoglobinuria) olwenziwe ekuseni. Kwacatshangwa ukuthi ukwehla okungavamile kwamangqamuzana egazi abomvu (i- hemolysis ) okwenza ukuba umchamo omnyama kwenzeke ekuqhumeni (ama-paroxysms) okwenzeka ebusuku. Nokho, ucwaningo lubonise ukuthi i-hemolysis e-PNH, ebangelwa ukukhubazeka kwezinto eziphilayo, kwenzeka nsuku zonke futhi ayitholakali.

Ukushintsha kombala womchamo kungenzeka nganoma isiphi isikhathi kepha kuyamangalisa kakhulu kumchamo wokulala ebusuku.

Ukuqonda okuthuthukisiwe kwe-paroxysmal nocturnal hemoglobinuria kuye kwahlenga kabusha lesi sifo njengokuba ne-hemolysis, ama- blood clots emithanjeni (thrombosis), nokuntuleka kokukhiqizwa kwazo zonke izinhlobo zamangqamuzana egazi ( hematopoiesis ). I-PNH ithinta bobabili abesilisa nabesifazane bazo zonke izizinda ezihlukahlukene futhi kungenzeka kunanoma yisiphi isikhathi, kodwa kuvame ukutholakala kubantu abadala.

Izimpawu

Abantu abaningi abane-PNH abanayo izimpawu. Izimpawu ze-PNH zixhomeke ekutheni i-hemolysis, i-thrombosis, noma i-hematopoiesis engakwazi yini.

Ukuxilongwa

Kunezivivinyo eziningana ze-laboratory ezingasiza ukuxilongwa kwe-paroxysmal nocturnal hemoglobinuria. Okucacile kakhulu ukuhlola igazi ukuthola i-CD55 ne-CD59, amaprotheni amabili.

Ukungabikho kwala maprotheni ngamaseli abomvu aqinisekisa ukuxilongwa kwe-PNH. Ngesikhathi sokuxilongwa, ezinye izivivinyo zegazi zizokwenziwa kufaka phakathi inani eliphelele le-cell (CBC), isibalo se-reticulocyte, i-serum lactate dehydrogenase (LDH), i-bilirubin, ne-haptoglobin. Isampuli yamathambo (i-biopsy) singathathwa bese sihlolwe ngaphansi kwe-microscope.

Ukwelapha

Ukwelashwa kusekelwe kuzo izimpawu ezikhona. Abantu abaningi abadala baphathwa nge-steroids (prednisone) nsuku zonke lapho i-hemolysis ikhona futhi ishintshela ezinsukwini ezingezansi ngesikhathi sokuxolelwa. I-Iron ne-folic acid supplements zisiza ukufaka esikhundleni sokulahlekelwa ngenxa ye-hemolysis. Abanye abantu bangathola ama-hormone e-androgenic ukugqugquzela ukukhiqizwa kwamaseli abomvu. E-anemia enamandla, ukumpompela igazi kungadingeka. I-Blood thinners ingasetshenziselwa ukunciphisa ukuthuthukiswa kwezindwangu zegazi. I-hematopoiesis engaphelele ingaphathwa nge-antithymocyte globulin (ATG).

Ukufakelwa kwe-marrow cell (stem cell) kungashintsha amangqamuzana egazi angenasici e-PNH ngejwayelekile. Cishe bonke abantu abane-PNH ekugcineni badinga ukufakelwa ukuze baphile isikhathi eside. Uma ukufakelwa kwenziwa ngemuva kwesikhathi esifundeni lesi sifo imiphumela ayifanele ngoba umuntu ugula kakhulu ngaleso sikhathi.

Imithi yokuqala ye-PNH ivunyelwe

Ngo-Mashi 16, 2007, i-US Food and Drug Administration (FDA) yamukele iSoliris (eculizumab) yokwelashwa kwe-PNH. Ukuvunywa kwakusekelwe emiphumeleni yezifundo eziningana ezabonisa ukuthi ukwelashwa nge-eculizumab kwaveza ukunciphisa okukhulu kwe-hemolysis, futhi izinsuku ze-hemoglobinuria inyanga ngayinye yehla.

Umthombo

> Parker, Charles, Mitsuhiro Omine, uStephen Richards, et al. "Ukuxilongwa Nokuphathwa Kwe-Paroxysmal Nocturnal Hemoglobinuria." Igazi 106 (2005): 3699 - 3709.